Blue Earth Therapeutics

Blue Earth Therapeutics is a clinical stage radiopharmaceutical company focused on developing targeted radiotherapeutics for cancer treatment. They have a pipeline of precision targeted radiopharmaceuticals.
  • Targeted radiopharmaceuticals
  • Precision targeted radiotherapeutics

Size
Small
Phone
N/A
Email
N/A
Locations
The Oxford Science Park, OX4 4GA
01865634500
Digital Popularity
Social Media
Competitors
Oxular
Oxular is transforming the treatment of retinal disorders to improve patients’ vision so they can live better lives.
Exscientia
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
Nucleome Therapeutics Limited
Nucleome Therapeutics is a biotechnology company focused on decoding the regulatory genome to develop first-in-class precision medicines.
Company Details
Blue Earth Therapeutics is operated by Blue Earth Therapeutics Limited and is a Active company incorporated on 26 February 2021 with the registered office located in Oxford, Oxfordshire. Blue Earth Therapeutics Limited was registered 4 years ago.

Status
Active
Size
Micro
Directors
10
Age
4 years old
Employees
6
Turnover
Unreported
Total Assets
£12M
Cash in Bank
£9.6M
Total Liabilities
-£3.03M

Director • Finance Director • Italian • Lives in Italy • Born in May 1965
Director • British • Lives in UK • Born in Aug 1971
Director • Investment Professional • American • Lives in United States • Born in Dec 1988
Director • French • Lives in France • Born in May 1970
Director • Italian • Lives in Italy • Born in Aug 1969
Director • Ceo • Italian • Lives in Italy • Born in Jun 1966
Teams
All
11
Management
6
Research
3
Legal
1
Other
2
Chief Executive Officer • Joined Jul 2024
Chief Operating Officer & General Counsel • Joined Oct 2024
Associate Director Pharmacovigilance • Joined Feb 2025
Supply Chain Manager • Joined Nov 2024
CMC Development Manager • Joined Jan 2025
Senior Clinical Trial Manager • Joined Dec 2024
Senior Director, Regulatory Affairs • Joined Jan 2024
Head Of CMC And Supply Chain • Joined Apr 2023
Medical Physicist • Joined May 2023
Chief Executive Officer • Joined Jul 2024
Chief Operating Officer & General Counsel • Joined Oct 2024
Associate Director Pharmacovigilance • Joined Feb 2025
Supply Chain Manager • Joined Nov 2024
Senior Clinical Trial Manager • Joined Dec 2024
Senior Clinical Trial Manager • Joined Dec 2024
Medical Physicist • Joined May 2023
Medical Physicist • Joined Jun 2023
Senior Director, Regulatory Affairs • Joined Jan 2024
CMC Development Manager • Joined Jan 2025
View 11 members